Viewing Study NCT00003305


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-01-08 @ 6:27 PM
Study NCT ID: NCT00003305
Status: COMPLETED
Last Update Posted: 2014-01-06
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Aminopterin in Treating Patients With Refractory Leukemia
Sponsor: Genzyme, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1997-07
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2007-09
Completion Date Type: ACTUAL
First Submit Date: 1999-11-01
First Submit QC Date: None
Study First Post Date: 2004-08-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-01-03
Last Update Post Date: 2014-01-06
Last Update Post Date Type: ESTIMATED